Aiberry vs Videra Health (2026)
Both read a person's face, voice and words to produce a mental health signal, and they are sold to different buyers with very different assurance behind them. Aiberry is a screening front door. Its products are anonymous with no sign in, sold to organizations as a way into care rather than as care, with one tier now published at five thousand dollars a year. The anonymity is a real minimization decision rather than a marketing line, and it also means no clinician sits between the model and the person answering. Videra Health is the clinical platform. It sends assessments, analyses what the patient says, how they say it and how they look while saying it, and returns the result into a behavioral health record system, naming Kipu, Alleva, BestNotes and BlueStep among seven. It publishes a redisclosure consent notice as a standing page, describes its handling controls in operational detail, and runs a public trust portal. The gap between them is what a buyer can check. Videra publishes a documented security program with the report behind an agreement. Aiberry's entire published security posture is a badge in the footer.
- Screening is the job and anonymity is the point: no sign in, no account, and a design that collects less rather than promising to protect more.
- One tier carries a published figure, which lets an organisation size the entry cost without a sales conversation.
- There is a real peer reviewed study behind the instrument, correctly disclosed in the journal.
- The result has to reach the chart: seven record systems are named, four of them behavioural health systems rather than general ones.
- Data handling is described in operational detail rather than asserted, with a redisclosure consent notice published as a standing page.
- Coverage runs across levels of care, including the populations where repeated structured assessment actually changes decisions.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Aiberry and Videra Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Aiberry | Videra Health |
|---|---|---|
| Primary category | Behavioral Health AI | Behavioral Health AI |
| Founded | Not recorded | 2019 |
| Headquarters | Seattle, Washington, United States | Orem, Utah, United States |
| Website | aiberry.com | viderahealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index records no top capability grade for Aiberry on any axis it scores. Set against Videra Health, Aiberry grades higher on AI Governance and Bias Disclosure and Commercial Transparency. Its thinnest published disclosure sits on several axes, including Model Supply Chain Disclosure, Security Certifications and Trust Center and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
The AI Health Index awards Videra Health its top capability grade on AI Centrality. Set against Aiberry, Videra Health grades higher on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Its thinnest published disclosure sits on AI Liability and Recourse and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
Questions buyers ask
Should we choose Aiberry or Videra Health?
On the axes where the AI Health Index separates them, Aiberry grades higher on AI Governance and Bias Disclosure and Commercial Transparency, and Videra Health grades higher on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Videra Health leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Aiberry and Videra Health differ most?
The widest separation the AI Health Index records between Aiberry and Videra Health is on Commercial Transparency, where Aiberry grades B and Videra Health grades D. That axis sits in the Commercial group, so it should carry the most weight for a buyer whose binding constraint is contracting, scope and what the price actually covers.
Where do Aiberry and Videra Health grade the same?
The AI Health Index grades Aiberry and Videra Health the same on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Aiberry and Videra Health not disclosed?
At the last review, at least one of Aiberry and Videra Health published thin or absent detail on several axes, including Model Supply Chain Disclosure, Security Certifications and Trust Center and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both make a clinical inference from voice, face and language, and neither publishes performance compared across accent, dialect, age or first language, which is the question this technology turns on. Videra asserts consistent performance across populations without per group results; Aiberry is the one record in this group that publishes any per group figure, and it is partial.
Videra's headline is a clinical outcome claim, a sixty four percent reduction in crisis driven interventions, and its published research measures agreement with clinical references rather than outcomes, so ask which study supports the number. Aiberry names no record system at all and presents the absence of integration as a feature; it publishes no security page, trust center or external attestation, and its compliance claim is a footer badge. Neither identifies any party in its model supply chain. Ask both what happens when the model flags someone at risk and nobody is watching the screen.